Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Epstein

Showing results (101-110 of 266) with videos related to

Pageof 27
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 6, 2017
Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Health & Social Work|May 23, 1998
Health care needs of medically underserved women of color: The role of the Bureau of Primary Health CareM H Gaston, S E Barrett, T L Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine AutoinjectorsTolly G Epstein, Gary M Liss, Karen Murphy Berendts, et al.
Archives of Neurology|December 1, 1991
Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implicationsK D Kieburtz, L G Epstein, H A Gelbard, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Muscle & Nerve|March 1, 1997
Familial autosomal-dominant carpal tunnel syndrome presenting in a 5-year-old-case report and review of the literatureA G Vadasz, P F Chance, L G Epstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 17, 2022
Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World StudyNajeeb Khan, Tolly G Epstein, Ilona DuBuske, et al.
Draper Fund Report|March 1, 1980
Population's political cloutM E Schima, B Viel, P C Chen, et al.
Journal of Neurovirology|April 1, 1997
Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron culturesD R New, M Ma, L G Epstein, et al.
AJNR. American Journal of Neuroradiology|January 1, 1987
Unilateral calcification and contrast enhancement of the basal ganglia in a child with AIDS encephalopathyL G Epstein, C Z Berman, L R Sharer, et al.
Pageof 27

Showing results (101-110 of 266) with videos related to

Sort By:
Pageof 27
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 6, 2017
Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Health & Social Work|May 23, 1998
Health care needs of medically underserved women of color: The role of the Bureau of Primary Health CareM H Gaston, S E Barrett, T L Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine AutoinjectorsTolly G Epstein, Gary M Liss, Karen Murphy Berendts, et al.
Archives of Neurology|December 1, 1991
Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implicationsK D Kieburtz, L G Epstein, H A Gelbard, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Muscle & Nerve|March 1, 1997
Familial autosomal-dominant carpal tunnel syndrome presenting in a 5-year-old-case report and review of the literatureA G Vadasz, P F Chance, L G Epstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 17, 2022
Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World StudyNajeeb Khan, Tolly G Epstein, Ilona DuBuske, et al.
Draper Fund Report|March 1, 1980
Population's political cloutM E Schima, B Viel, P C Chen, et al.
Journal of Neurovirology|April 1, 1997
Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron culturesD R New, M Ma, L G Epstein, et al.
AJNR. American Journal of Neuroradiology|January 1, 1987
Unilateral calcification and contrast enhancement of the basal ganglia in a child with AIDS encephalopathyL G Epstein, C Z Berman, L R Sharer, et al.
Pageof 27